Company: CERO
Filing Date: 2025-06-02
Form Type: 8-K
Source: 0001213900-25-050055
Chunk: 0

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-02
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item
9.01 Financial Statements and Exhibits

.

(d) Exhibits.

  Exhibit No.      Description                                                                                                             
  10.1*+           Employment Agreement by and between CERo Therapeutics Holdings, Inc., and Chris Ehrlich, dated May 30, 2025             
  10.2*+           Employment Agreement by and between CERo Therapeutics Holdings, Inc., and Andrew Albert Kucharchuk, dated May 30, 2025  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document)                                             

  Filed herewith.                                      
  Indicates management contract or compensatory plan.  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: June 2, 2025      cERO THERAPEUTICS HOLDINGS, Inc.                               
 ─────────────────────────────────────────────────────────────────────────────────────────
                          By:                                   /s/ Chris Ehrlich        
                          Name:                                 Chris Ehrlich            
                          Title:                                Chief Executive Officer